Australia-based radiopharmaceutical company Telix Pharmaceuticals has created a new radionuclide generator that could facilitate the commercial supply of lead-212 isotope-based therapies. The company ...
BERLIN--(BUSINESS WIRE)--Eckert & Ziegler Radiopharma GmbH has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) for its pharmaceutical 68 Ge/ 68 Ga generator for the ...
The issuer is solely responsible for the content of this announcement. August 5, 2024 - Berlin - Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) has received approval from the European Commission ...
This section is intended to provide hints and answers to some Frequently Asked Questions (FAQ) in relation with the activities of the International Atomic Energy Agency (IAEA) in Nuclear Medicine (NMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results